The decline in A-share innovative drug concept stocks widened in the afternoon, with Biocytogen and Baicheng Pharmaceutical hitting the 20cm daily limit down, and many other stocks such as Yaokang Bio, Hongbo Pharmaceutical, Frontier Biotech, and War

2026-07-17

The decline in A-share innovative drug concept stocks widened in the afternoon, with Biocytogen and Baicheng Pharmaceutical hitting the 20cm daily limit down, and many other stocks such as Yaokang Bio, Hongbo Pharmaceutical, Frontier Biotech, and Warner Pharmaceutical falling by more than 10%.